Literature DB >> 20097305

SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity.

Sandeep Singh1, Kadreppa Sreenath, Lakshminarasimhan Pavithra, Siddhartha Roy, Samit Chattopadhyay.   

Abstract

Tumor suppressor SMAR1 is known to be involved in regulation of cell cycle and apoptotic genes transcription. It also directly interacts and stabilizes p53 through phosphorylation at serine-15 residue. Although the functions of SMAR1 are mainly restricted to the nucleus, we report its novel function with the cytoplasm. We show that SMAR1 directly interacts and inhibits AKR1a4 enzyme activity. Interestingly, AKR1a4 enzyme activity is elevated in higher grades of breast cancer where SMAR1 expression is drastically downregulated. Higher AKR1a4 activity protects the cancer cells from anticancer drugs and free radical stress. Through increased metabolism, ARK1a4 helps fulfilling higher energy needs required by cancer cell. The present study delineates yet another facet of tumor suppressor activity of SMAR1 in the cytoplasm. We also depict that upon stress, ATM kinase leads to dissociation of SMAR1-AKR1a4 complex through nuclear translocation of SMAR1 causing elevated AKR1a4 activity. Nuclear SMAR1 causes cell cycle arrest giving ample time for DNA damage repair, while AKR1a4 scavenges the excess free radicals which may further cause DNA damage. Thus, we propose a novel mechanism of regulation of oxidative stress by ATM through modulation of SMAR1-AKR1a4 complex. Further, we show that a small peptide derived from SMAR1 induces free radical stress by inhibiting AKR1a4 enzyme activity, which can be a potential anticancer therapeutic agent. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097305     DOI: 10.1016/j.biocel.2010.01.022

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

Review 2.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

3.  Influence of metabolic stress on translation of p53 isoforms.

Authors:  Debjit Khan; Samit Chattopadhyay; Saumitra Das
Journal:  Mol Cell Oncol       Date:  2015-05-05

4.  High-resolution structure of AKR1a4 in the apo form and its interaction with ligands.

Authors:  Frédérick Faucher; Zongchao Jia
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-26

5.  Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment.

Authors:  Sandeep Singh; Varsheish Raina; Pavithra Lakshminarsimhan Chavali; Taronish Dubash; Sreenath Kadreppa; Pradeep Parab; Samit Chattopadhyay
Journal:  BMC Mol Biol       Date:  2012-09-14       Impact factor: 2.946

6.  Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.

Authors:  Kai Connie Wu; Julia Yue Cui; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 7.  Involvement of free radicals in breast cancer.

Authors:  Sandra Ríos-Arrabal; Francisco Artacho-Cordón; Josefa León; Elisa Román-Marinetto; María Del Mar Salinas-Asensio; Irene Calvente; Maria Isabel Núñez
Journal:  Springerplus       Date:  2013-08-27

Review 8.  Control of Translation at the Initiation Phase During Glucose Starvation in Yeast.

Authors:  Yoshika Janapala; Thomas Preiss; Nikolay E Shirokikh
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

Review 9.  Pleiotropic Actions of Aldehyde Reductase (AKR1A).

Authors:  Junichi Fujii; Takujiro Homma; Satoshi Miyata; Motoko Takahashi
Journal:  Metabolites       Date:  2021-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.